跳至主要内容
临床试验/IRCT20090801002266N11
IRCT20090801002266N11招募中3 期

Efficacy of Add-on Memantine to clonidine on severity of opioid substances (heroin and opium) withdrawal symptoms among opium users

Esfahan University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • Consent to participate in the study
  • DSM-IV criteria for drug dependence
  • Regular and daily use of opium orally, injectable or smoke

排除标准

  • Non-use of psychiatric drugs and other substances other than cigarettes
  • Taking pain medications
  • Comorbid of major psychiatric disorders
  • Physical illness that is a prohibition on quitting drugs.

研究者

相似试验